Quick Nav
Pharmacy Times

compounding HOTLINE

Martin A. Erickson III, RPh
Published Online: Wednesday, August 1, 2007   [ Request Print ]

A patient complained of redness at the site of application of a topical, transdermal (poloxamer-lecithin organogel?based) preparation. The patient applied the same material at the same site over the past 6 months. Suggestions?
Click Here For The Answer -----------> [-]
Generally, patients should be encouraged to rotate sites of application of extemporaneously prepared formulations intended for transdermal administration of active ingredients, particularly when occlusive dressing technique is employed. Consult with the patient about areas where the epidermis is thin and where hair growth is thinnest.
Related Articles
No Result Found

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.

Become a Member
Forgot Password?